XENE

XENE Change in Working Capital

$13.06MTTM · USD

Period ending:

XENE FY Change in Working CapitalUSD
XENE FY Change in Working Capital2011-12-31: -$3.27M2012-12-31: $47.42M2013-12-31: -$16.68M2014-12-31: -$14.26M2015-12-31: -$13.96M2016-12-31: $1.77M2017-12-31: $556.00K2018-12-31: $30.00K2019-12-31: $33.52M2020-12-31: -$26.09M2021-12-31: -$2.65M2022-12-31: -$676.00K2023-12-31: $5.64M2024-12-31: $5.71M2025-12-31: $4.36M$47.42M-$26.09M
2011-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

XENE change in working capital history

Working capital impact on cash flow. The available annual fiscal periods series contains 15 observations from Dec 31, 2011 to Dec 31, 2025.

Xenon Pharmaceuticals Inc Change in Working Capital — Annual fiscal periods (USD)
Period endingChange in Working Capital (USD)
4,360,000
5,713,000
5,635,000
-676,000
-2,647,000
-26,089,000
33,520,000
30,000
556,000
1,768,000
-13,957,000
-14,256,000
-16,675,000
47,418,000
-3,266,000

Compare change in working capital

All XENE financial metrics · XENE stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.